2020 BioCap Conference Call for Pitches Competition Finalists Announced

Published on 12/11/2020
2020 BioCap Conference Call for Pitches Competition Finalists Announced Bionow and Catapult Ventures is delighted to announce the 'Call for Pitches' finalists for this years' BioCap Conference

The BioCap Conference provides a unique meeting place connecting life sciences businesses, researchers and investors. Join us in navigating the life sciences funding landscape and identifying the life science investment opportunities that will advance and support the success of your business. This not to be missed conference offers a great opportunity to further discuss future collaborations in one-to-one meetings. Helping businesses to realise their full potential, whatever your funding requirements are.

The 'Call for Pitches' competition invited established life science businesses who are seeking or shortly starting to seek funding of £250k or above to submit an application for the opportuity to present to a panel of investors their company overview, request and need for funding in an 8 minute digital pitch.

The competition kindly sponsored by Catapult Ventures once again proved to be hugely popular this year and the judging committee were impressed with the number and quality of the applications received. 

The finalists are:
  • AEH Innovative Hydrogel
  • CanSense
  • Erebagan
  • Gendius
  • InfexTherapeutics
  • Lightox
  • Nanovery
  • Phion Therapeutics
  • Ubiquigent Limited
  • Veritacell
We would like to thank all of the companies who submitted an application and we look forward to seeing you all at the conference.

If you are looking to invest in innovative life science companies or seeking investment for your business? BioCap is the conference to achieve this! 

Investors attending the conference this year:
Albion Capital Group LLP, Amadeus Capital Partners, aMoon, Apposite Capital LLP, Bamburgh Capital, Bridge Valley Ventures, British Business Bank, Catapult Ventures, China Investors Club, CPI Corporate Venturing, Debiopharm International SA, Downing LLP, DSW Ventures, Eli Lilly, Epidarex, FMG Ventures, Hadean Ventures, Ignite Capital Partners, Inc., Inkef Capital, Innovate UK, JJDC, L&G, Legal and General, LifeArc, London Stock Exchange plc, Longwall Ventures, M Ventures BV, Maven Capital Partners, Meltwind Advisory,  Mercia Asset Management, MTI Partners, Newable Ventures, NorthInvest, Novartis Ventures, Optum Ventures, Oyster Venture Partners, Peel Hunt LLP, Perscitus LLP, Praetura Ventures, Saiga, SFC Capital, Shore Capital, SP Angel, Symmetrist, Independent Investors and Others to Follow........

For further information and to register click HERE.


Our Valued Sponsors & Partners